Table of Contents
Journal of Angiology
Volume 2014, Article ID 420937, 6 pages
http://dx.doi.org/10.1155/2014/420937
Clinical Study

Pregnancy-Associated Plasma Protein-A Levels and Coronary Angiographic Features in Acute Coronary Syndrome Patients

Department of Cardiology, Faculty of Medicine, Ain Shams University, P.O. Box 11381, Abbassia, Cairo, Egypt

Received 30 September 2013; Revised 16 December 2013; Accepted 24 December 2013; Published 4 February 2014

Academic Editor: Apostolos E. Papalois

Copyright © 2014 Mohamed Shehata. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Naghavi, P. Libby, E. Falk et al., “From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies—part I,” Circulation, vol. 108, no. 14, pp. 1664–1672, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Bayes-Genis, C. A. Conover, M. T. Overgaard et al., “Pregnancy-associated plasma protein A as a marker of acute coronary syndromes,” New England Journal of Medicine, vol. 345, no. 14, pp. 1022–1029, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Libby, “Inflammation in atherosclerosis,” Nature, vol. 420, no. 6917, pp. 868–874, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Ross, “Atherosclerosis—an inflammatory disease,” New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. L. S. Laursen, M. T. Overgaard, C. G. Nielsen et al., “Substrate specificity of the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysis,” Biochemical Journal, vol. 367, no. 1, pp. 31–40, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Lund, Q.-P. Qin, T. Ilva et al., “Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation,” Circulation, vol. 108, no. 16, pp. 1924–1926, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Heeschen, S. Dimmeler, C. W. Hamm, S. Fichtlscherer, M. L. Simoons, and A. M. Zeiher, “Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis,” Journal of the American College of Cardiology, vol. 45, no. 2, pp. 229–237, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. C. Smith Jr., J. T. Dove, A. K. Jacobs et al., “American College of Cardiology; American Heart Association Task Force on Practice Guidelines. Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)—executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty),” Journal of the American College of Cardiology, vol. 37, no. 8, pp. 2215–2239, 2001. View at Google Scholar
  9. C. J. Terkelsen, C. Oxvig, and B. L. Nørgaard, “Temporal course of pregnancy-associated plasma protein-A in angioplasty-treated ST-segment elevation myocardial infarction patients and potential significance of concomitant heparin administration,” American Journal of Cardiology, vol. 103, no. 1, pp. 29–35, 2009. View at Publisher · View at Google Scholar
  10. P. Hájek, M. Macek Sr., M. Pešková et al., “High positive predictive value of PAPP-A for acute coronary syndrome diagnosis in heparin-naïve patients,” Journal of Thrombosis and Thrombolysis, vol. 34, no. 1, pp. 99–105, 2012. View at Publisher · View at Google Scholar
  11. C. W. Hamm, B. U. Goldmann, C. Heeschen, G. Kreymann, J. Berger, and T. Meinertz, “Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I,” New England Journal of Medicine, vol. 337, no. 23, pp. 1648–1653, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Braunwald, “Unstable angina: an etiologic approach to management,” Circulation, vol. 98, no. 21, pp. 2219–2222, 1998. View at Google Scholar · View at Scopus
  13. J. Cosin-Sales, J. C. Kaski, M. Christiansen et al., “Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris,” European Heart Journal, vol. 26, no. 20, pp. 2093–2098, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J.-L. Liu, H. Zhang, X.-J. Xie, L. Chen, and C.-L. Zhao, “Changes of pregnancy-associated plasma protein-A in patients with acute coronary syndrome,” Chinese Medical Journal, vol. 118, no. 21, pp. 1827–1829, 2005. View at Google Scholar · View at Scopus
  15. T. Stulc, I. Malbohan, and J. Malík, “Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia: the effect of atorvastatin treatment,” American Heart Journal, vol. 146, no. 6, article E21, 2003. View at Google Scholar
  16. J. Khosravi, A. Diamandi, R. G. Krishna, U. Bodani, J. Mistry, and N. Khaja, “Pregnancy associated plasma protein-A: ultrasensitive immunoassay and determination in coronary heart disease,” Clinical Biochemistry, vol. 35, no. 7, pp. 531–538, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. O. F. Laterza, S. J. Cameron, D. Chappell, L. J. Sokoll, and G. B. Green, “Evaluation of pregnancy-associated plasma protein A as a prognostic indicator in acute coronary syndrome patients,” Clinica Chimica Acta, vol. 348, no. 1-2, pp. 163–169, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. M. P. Bonaca, B. M. Scirica, M. S. Sabatine et al., “Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes,” Journal of the American College of Cardiology, vol. 60, no. 4, pp. 332–338, 2012. View at Publisher · View at Google Scholar
  19. W. Y. Mei, Z. M. Du, Q. Zhao et al., “Pregnancy-associated plasma protein predicts outcomes of percutaneous coronary intervention in patients with non-ST-elevation acute coronary syndrome,” Heart Lung, vol. 40, no. 3, pp. e78–e83, 2011. View at Publisher · View at Google Scholar
  20. M. D. Miedema, C. A. Conover, H. MacDonald et al., “Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy,” American Journal of Cardiology, vol. 101, no. 1, pp. 35–39, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Aarsetøy, T. Brügger-Andersen, Ø. Hetland, H. Grundt, and D. W. T. Nilsen, “Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metalloproteinase-9 following acute myocardial infarction,” Thrombosis and Haemostasis, vol. 95, no. 2, pp. 329–336, 2006. View at Publisher · View at Google Scholar · View at Scopus